-
Two hundred 'Cruise for life' passengers stranded in Cambodia
-
India vows action after first cheetah shot dead
-
Pierce Brosnan and Helen Mirren on the joys of filming 'MobLand'
-
'Now or Never': Ethiopia influencers push for Eritrea invasion
-
S.African activists push back on data centre rush
-
Mbappe furore rages on in China, but Mao comments censored
-
Judges set to rule on Australian mushroom killer's appeal
-
Billionaire Ambani's Jio jumps 21% in market debut after record India IPO
-
Syria reopens Jordan border crossing after mending ties
-
Rays win thriller to thwart Brewers in World Series
-
Cyclone Arnab lashes India coast, no deaths reported
-
Reigning champ Knicks earn first win against Pistons
-
Trump tamed after US midterms? Europe doubts it
-
Runners swap streets for shopping malls as haze chokes Singapore
-
Tech stocks soar as SK hynix adds to rising AI confidence
-
Billionaire Ambani's Jio to debut after record India IPO
-
Sri Lanka's Tamil farmers fight to reclaim land after civil war
-
UK set for cautious budget as borrowing costs climb
-
Afghans compete for jobs, homes as millions return
-
Anthropic's record IPO faces some big questions
-
'They don't care about us': Trump food aid cuts leave Americans struggling and angry
-
US Fed expected to hold rates steady ahead of key midterm elections
-
Meta, Snap head to trial in another case about social media's harms
-
Can this Latin Grammy-winner help Democrats win back Congress?
-
French Senate passes bill to make protesters pay for unrest damage
-
Tuvalu has 'limited' power to halt its fossil fuel investments: NZ govt papers seen by AFP
-
India evacuates tens of thousands as Cyclone Arnab makes landfall
-
Palestinian activist Khalil returns to Columbia after US detention
-
In tight Israel vote, both camps hold out cautious hope
-
Trump drastically loosens oil and gas methane rules
-
AI chip giant SK hynix says quarterly operating profit soars 630%
-
French Senate weighs bill to make protesters pay for unrest damage
-
Youths testify about 'despair' in unprecedented Canadian climate trial
-
Fulcrum Metals PLC Announces Uranium Targets Identified at Charlot-Neely
-
Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 28
-
6 Weekend Upgrades That Increase Your Property Value
-
'A very sad day': Arteta despair as Arsenal stunned by Fleetwood
-
Syria, Jordan agree to mend ties after deadly strike
-
Charles tackles thorny legacy of slavery on Caribbean trip
-
Arsenal stunned by fourth-tier Fleetwood in League Cup
-
Former Grand Slam winner Wawrinka ends tennis career
-
Last-gasp Sabitzer strike sends Dortmund past Bremen in German Cup
-
Brazil's Flavio Bolsonaro flees to US after election loss
-
Rights groups reject Emirati diplomat for UN top job
-
'Faerie' nights: 'ACOTAR' fans finally get their book
-
Flavio Bolsonaro headed to US after Brazil election defeat: US media
-
American woman convicted of getting military training from Islamic State
-
Alcaraz and Zverev win Vienna openers
-
Israel opposition holds narrow edge over Netanyahu in first projections
TIDI Products Names Jim Rubright as President & CEO
NEENAH, WI / ACCESS Newswire / July 8, 2025 / TIDI Products, LLC, a leading manufacturer of consumable medical products focused on enhancing patient safety and reducing contamination risk, is pleased to announce that Jim Rubright has been named President & Chief Executive Officer. Rubright succeeds Kevin McNamara, who has led the Company since 2005. Rubright will begin his new role immediately, and McNamara will continue to help drive the organization's strategic vision as the Company's Chairman of the Board.
Rubright brings a wealth of experience and a continuity of leadership to his new role, having served as TIDI's Vice President & Chief Financial Officer since joining the Company in 2014. As a member of the Executive Leadership Team, Rubright has worked closely with McNamara and other team members to help guide the Company's growth and evolution. Key milestones during Rubright's tenure to date include TIDI's 2017 acquisition of the J.T. Posey Company and TIDI's 2023 sale to TJC, LP, a private equity firm.
"Constancy of purpose is a vital hallmark of our approach to business," says McNamara. "We embrace opportunities to fulfill TIDI's mission, which is to Support Caregivers and Protect Patients. That is our True North."
"TIDI's success rests on our ability to provide innovative, reliable medical devices that support caregivers and protect patients," adds Rubright. "Doing so allows us to build trust and create a positive impact on our customers and communities. I believe everyone at TIDI is excited about what we can achieve."
About TIDI Products
Based in Neenah, Wisconsin, TIDI Products provides an extensive range of forward-looking safety solutions to healthcare professionals - solutions that help these professionals deliver the highest-quality patient care. The TIDI Products portfolio of brands includes Posey®, C-Armor®, Sterile-Z®, AquaGuard®, Grip-Lok®, TIDIShield®, and Zero-Gravity®. For more information, visit www.tidiproducts.com.
For additional inquiries or information please reach out to TIDI Customer Service: 1 800.521.1314 or Email: [email protected]
SOURCE: TIDI Products
View the original press release on ACCESS Newswire
A.Taylor--AT